Danaher (DHR)
(Real Time Quote from BATS)
$275.26 USD
+3.61 (1.33%)
Updated Jul 30, 2024 03:53 PM ET
After-Market: $275.22 -0.04 (-0.01%) 4:14 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$275.26 USD
+3.61 (1.33%)
Updated Jul 30, 2024 03:53 PM ET
After-Market: $275.22 -0.04 (-0.01%) 4:14 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Zacks News
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products.
General Electric's (GE) GECAS Unit to Divest PK AirFinance
by Zacks Equity Research
General Electric's (GE) financial services unit GE Capital's divestment of PK AirFinance will help it progress on its plan to divest assets worth $10 billion in 2019.
Carlisle (CSL) Rises 41% YTD: What's Driving the Stock?
by Zacks Equity Research
Carlisle (CSL) surges year to date, outperforming the industry and the S&P 500. Healthy end-market businesses, acquired assets and shareholder-friendly policies are supporting its share price rally.
UTX or DHR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
UTX vs. DHR: Which Stock Is the Better Value Option?
Danaher Gains From Rising Product Demand Despite High Costs
by Zacks Equity Research
Danaher's (DHR) solid product portfolio and focus on innovation are boons. However, rise in costs and expenses as well as high debts and forex woes are concerning.
Danaher (DHR) Down 1.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UTX vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UTX vs. DHR: Which Stock Is the Better Value Option?
Is Danaher (DHR) Stock Outpacing Its Conglomerates Peers This Year?
by Zacks Equity Research
Is (DHR) Outperforming Other Conglomerates Stocks This Year?
ITT's Q2 Earnings and Revenues Surpass Estimates, Up Y/Y
by Zacks Equity Research
ITT's second-quarter earnings and revenues rise year over year on the back of solid performance across Industrial Process and Connect & Control Technologies segments.
Macquarie Infrastructure's (MIC) Q2 Earnings Decline Y/Y
by Zacks Equity Research
Macquarie Infrastructure's (MIC) second-quarter earnings decline year over year on account of higher selling, general and administrative and depreciation costs and rise in interest expenses.
General Electric (GE) Beats Q2 Earnings Estimates, Ups View
by Zacks Equity Research
General Electric's (GE) second-quarter 2019 earnings decline year over year due to weakness in sales and margins. However, earnings beat estimates by 41.7%. It raises earnings view for 2019.
3M (MMM) Q2 Earnings and Sales Beat Estimates, Down Y/Y
by Zacks Equity Research
3M's (MMM) second-quarter 2019 results suffer from forex woes, adverse impact of divestitures and weak organic sales. However, its earnings and sales surpass respective estimates.
Carlisle (CSL) Q2 Earnings & Revenues Top Estimates, Up Y/Y
by Zacks Equity Research
Carlisle's (CSL) second-quarter 2019 results benefit from growth in organic sales, acquired assets and margin improvement.
United Technologies' (UTX) Q2 Earnings and Revenues Beat
by Zacks Equity Research
United Technologies' (UTX) Q2 earnings jump year over year on the back of solid performance across most of its segments.
Crane (CR) Beats Earnings Estimates in Q2, Declares Dividend
by Zacks Equity Research
Crane's (CR) second-quarter 2019 results gain from a decline in costs and expenses, and hence, better margin profile. It declares a dividend to be paid in September.
CR vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
CR vs. DHR: Which Stock Is the Better Value Option?
Is Danaher (DHR) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Danaher (DHR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Danaher (DHR) Beats on Q2 Earnings and Sales, Ups Guidance
by Zacks Equity Research
Danaher's (DHR) second-quarter 2019 results benefit from growth in organic sales, acquired assets and DBS initiatives. Furthermore, the company raises its projection for the current year.
Honeywell (HON) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Impressive traction of long-cycle businesses in defense, commercial aerospace, process automation and building technologies drives Honeywell's (HON) Q2 results.
Danaher (DHR) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Danaher (DHR) delivered earnings and revenue surprises of 3.48% and 1.40%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Pfizer, Danaher, Tesla and Cintas
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Pfizer, Danaher, Tesla and Cintas
Will Danaher's (DHR) Products & Buyouts Drive Q2 Earnings?
by Zacks Equity Research
Danaher (DHR) might gain from healthy demand for products, solid execution, acquired assets and Danaher Business System in the second quarter of 2019. Forex woes remain concerning.
Top Research Reports for Berkshire Hathaway, Pfizer & Danaher
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Pfizer (PFE) and Danaher (DHR).
Danaher (DHR) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Danaher (DHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Danaher (DHR) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ITT vs. DHR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ITT vs. DHR: Which Stock Is the Better Value Option?